As with any medical treatment, individual experiences will vary
The approval processes and patent protections associated with these treatments can create barriers for new competitors, allowing existing products to maintain higher prices
GLP-1 inhibits intestinal contractions through mechanisms that may involve the central nervous system via vagal pathways or direct action on central receptors [24], as well as the enteric nervous system by modulating neurotransmission through presynaptic receptors affecting nitric oxide release [25,26]
GLP-1 medications are a class of drugs that mimic a hormone called glucagon-like peptide-1, which helps regulate blood sugar and appetite
Specifically, they proposed an approach in which GLP-1RAs could be prescribed for an initial period of weight loss before patients transitioned to cheaper alternative interventions for weight maintenance such as lower-cost medications, behavioral health programs and support from nutritionists
Compensation in such cases may cover medical expenses, lost income, pain and suffering, and other damages, depending on individual circumstances